Because excitotoxicity may be involved in neurodegeneration in Alzheimer's
disease, we investigated possible modifications of platelet glutamate uptak
e in AD patients. High-affinity glutamate uptake was studied in platelets f
rom 35 Alzheimer's disease patients, 10 multi-infarct dementia patients, an
d 35 age-matched normal controls; it was decreased by 40% in platelets from
Alzheimer's disease patients compared with controls and with multi-infarct
dementia patients. Platelet glutamate uptake could be used as peripheral m
arker of glutamatergic involvement and as adjunctive diagnostic tool in Alz
heimer's disease patients.